Health & Nutrition

Insulet Corporation to Report Second Quarter 2012 Financial Results on August 8, 2012

BEDFORD, MA: ...

Global Diabetes Rates to Catapult to 552 Million by 2030

NEW YORK, NY: ...

EnteroMedics to Host Second Quarter 2012 Financial Results Conference Call and Provide Business Update

ST. PAUL, MN: ...

Auxogyn Receives CE Mark for Non-Invasive Early Embryo Viability Assessment (Eeva) Test

MENLO PARK, CA: Company Launches Eeva™ Test in the European Union (EU) Company Submits 510(k) Filing to U.S. Food and Drug Administration (FDA) ...

Phrixus Pharmaceuticals, Inc. Reports Positive Preclinical Results in Respiratory Disease in Duchenne Muscular Dystrophy After Subcutaneous Delivery of Carmeseal(TM) at Very Low Doses

ANN ARBOR, MI: Results Extend the Utility of Carmeseal™ From Cardiac Disease to Respiratory Disease, the Main Cause of Mortality in Boys With DMD ...

Immunotec Announces President Departure

VAUDREUIL-DORION, QUEBEC: ...

The Jean Coutu Group: First Quarter of Fiscal Year 2013 Results

LONGUEUIL, QUEBEC: ...

Silent Call Communications' Receiver Watch Provides Mobility

WATERFORD, MI: ...

Pfizer Grants ChemRar Group Exclusive License to DPP-IVi Type 2 Diabetes Candidate

MOSCOW: ...

Health Enhancement Products to Hold Annual Shareholder Meeting July 18, 2012 in Detroit, Michigan

BLOOMFIELD HILLS, MI: ...